Shandong Cancer Hospital, Shandong University, Jinan, Shandong 250012, China; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
Department of Medicinal Chemistry and Key Laboratory of Chemical Biology of Natural Products (MOE), School of Pharmacy, Shandong University, Jinan, Shandong 250012, China.
Bioorg Med Chem. 2020 Aug 15;28(16):115607. doi: 10.1016/j.bmc.2020.115607. Epub 2020 Jun 30.
Research interest in the development of histone deacetylase 8 (HDAC8) activators has substantially increased since loss-of-function HDAC8 mutations were found in patients with Cornelia de Lange syndrome (CdLS). A series of N-acetylthioureas (e.g., TM-2-51) have been identified as HDAC8-selective activators, among others; however, their activation mechanisms remain elusive. Herein, we performed molecular dynamics (MD) simulations and fragment-centric topographical mapping (FCTM) to investigate the mechanism of HDAC8 activation. Our results revealed that improper binding of the coumarin group of fluorescent substrates leads to the "flipping out" of catalytic residue Y306, which reduces the enzymatic activity of HDAC8 towards fluorescent substrates. A pocket between the coumarin group of the substrate and thed catalytic residue Y306 was filled with the activator TM-2-51, which not only enhanced binding between HDAC8 and the fluorescent substrate complex but also stabilized Y306 in a catalytically active conformation. Based on this newly proposed substrate-dependent activation mechanism, we performed structure-based virtual screening and successfully identified low-molecular-weight scaffolds as new HDAC8 activators.
自发现 Cornelia de Lange 综合征(CdLS)患者存在功能丧失的组蛋白去乙酰化酶 8(HDAC8)突变以来,人们对 HDAC8 激活剂的研究兴趣大幅增加。已经鉴定出一系列 N-乙酰基硫脲(例如 TM-2-51)作为 HDAC8 选择性激活剂,但它们的激活机制仍不清楚。在此,我们进行了分子动力学(MD)模拟和基于片段的拓扑映射(FCTM),以研究 HDAC8 激活的机制。我们的结果表明,荧光底物中香豆素基团的不当结合导致催化残基 Y306 的“翻转”,从而降低了 HDAC8 对荧光底物的酶活性。底物的香豆素基团和催化残基 Y306 之间的口袋被激活剂 TM-2-51 填满,这不仅增强了 HDAC8 与荧光底物复合物的结合,而且还稳定了 Y306 的催化活性构象。基于这个新提出的底物依赖性激活机制,我们进行了基于结构的虚拟筛选,并成功鉴定出低分子量支架作为新的 HDAC8 激活剂。